Anaplastic thyroid carcinoma: The failure of conventional therapy but the real promise of targeted therapy

2015 ◽  
Author(s):  
Paul Lennon ◽  
Sandra Deady ◽  
Marie-Louise Healy ◽  
John Kinsella ◽  
Conrad Timon ◽  
...  
Head & Neck ◽  
2016 ◽  
Vol 38 (S1) ◽  
pp. E1122-E1129 ◽  
Author(s):  
Paul Lennon ◽  
Sandra Deady ◽  
Maire L. Healy ◽  
Mary Toner ◽  
John Kinsella ◽  
...  

2016 ◽  
Vol 12 (6) ◽  
pp. 511-518 ◽  
Author(s):  
Maria E. Cabanillas ◽  
Mark Zafereo ◽  
G. Brandon Gunn ◽  
Renata Ferrarotto

Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans and accounts for one to two cases per million persons annually. The rarity of this malignancy and the rapidity by which it grows has been a major barrier to progress in finding effective therapies. Thus, the treatment that is the current standard of care for these patients is largely palliative, and few are cured; however, novel therapies and approaches are being studied in patients with anaplastic thyroid carcinoma and are delineated herein.


Thyroid ◽  
2018 ◽  
Vol 28 (1) ◽  
pp. 79-87 ◽  
Author(s):  
Priyanka C. Iyer ◽  
Ramona Dadu ◽  
Renata Ferrarotto ◽  
Naifa L. Busaidy ◽  
Mouhammed A. Habra ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (26) ◽  
pp. 42613-42620 ◽  
Author(s):  
Vera Tiedje ◽  
Saskia Ting ◽  
Thomas Herold ◽  
Sarah Synoracki ◽  
Soeren Latteyer ◽  
...  

2015 ◽  
Vol 122 (03) ◽  
Author(s):  
V Tiedje ◽  
M Kroiß ◽  
K Lorenz ◽  
S Ting ◽  
M Stuschke ◽  
...  

2014 ◽  
Author(s):  
Husniye Baser ◽  
Mina Gulfem Kaya ◽  
Sefika Burcak Polat ◽  
Ersin Gurkan Dumlu ◽  
Canan Altunkaya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document